Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
AMTI

AMTI - Applied Molecular Transport Inc. Stock Price, Fair Value and News

0.26USD Market Closed
Watchlist

Market Summary

USD0.26
Market Closed

AMTI Stock Price

View Fullscreen

AMTI RSI Chart

AMTI Valuation

Market Cap

10.7M

Price/Earnings (Trailing)

-0.14

Price/Free Cashflow

-0.18

AMTI Price/Sales (Trailing)

AMTI Profitability

Return on Equity

-460.5%

Return on Assets

-373.65%

Free Cashflow Yield

-562.81%

AMTI Fundamentals

AMTI Earnings

Earnings (TTM)

-74.8M

Earnings Growth (Yr)

72.48%

Earnings Growth (Qtr)

59.98%

Breaking Down AMTI Revenue

Last 7 days

-16.1%

Last 30 days

62.5%

Last 90 days

65.6%

Trailing 12 Months

-40.2%

How does AMTI drawdown profile look like?

AMTI Financial Health

Current Ratio

4.99

AMTI Investor Care

Shares Dilution (1Y)

6.15%

Diluted EPS (TTM)

-1.89

Tracking the Latest Insider Buys and Sells of Applied Molecular Transport Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Dec 27, 2023
vandevender aaron
back to issuer
-
-
-212,659
-
Dec 27, 2023
cross shawn
back to issuer
-
-
-545,499
ceo & chair of the board
Dec 27, 2023
mahmood tahir ph.d.
back to issuer
-
-
-3,208,310
-
Dec 27, 2023
hants brandon
back to issuer
-
-
-301,225
cfo
Dec 27, 2023
mahmood tahir ph.d.
back to issuer
-
-
-391,693
-
Dec 27, 2023
epiq capital group, llc
sold
-
-
-8,337,520
-
Dec 27, 2023
mahmood tahir ph.d.
back to issuer
-
-
-484,738
-
Nov 22, 2023
cross shawn
sold
-18,116
0.1635
-110,802
ceo & chair of the board
Nov 22, 2023
hants brandon
sold
-10,054
0.1635
-61,494
cfo
Nov 22, 2023
mahmood tahir ph.d.
sold
-46,784
0.1634
-286,320
-

1–10 of 50

Which funds bought or sold AMTI recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Feb 15, 2024
JANE STREET GROUP, LLC
sold off
-100
-4,210
-
-%
Feb 14, 2024
VANGUARD GROUP INC
sold off
-100
-136,024
-
-%
Feb 14, 2024
Royal Bank of Canada
sold off
-100
-
-
-%
Feb 14, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC
sold off
-100
-7,850
-
-%
Feb 14, 2024
TWO SIGMA INVESTMENTS, LP
sold off
-100
-7,843
-
-%
Feb 14, 2024
Laurion Capital Management LP
sold off
-100
-34,199
-
-%
Feb 14, 2024
Founders Fund V Management, LLC
sold off
-100
-567,024,000
-
-%
Feb 14, 2024
Founders Fund VI Management, LLC
sold off
-100
-129,777
-
-%

1–10 of 38

Are Funds Buying or Selling AMTI?

Are funds buying AMTI calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own AMTI
No. of Funds

Unveiling Applied Molecular Transport Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
founders fund v management, llc
0.0%
0
SC 13G/A
Jan 05, 2024
epiq capital group, llc
0%
0
SC 13D/A
Feb 09, 2023
mahmood tahir ph.d.
9.69%
3,791,803
SC 13G/A
Feb 03, 2023
mrsny randall ph.d.
9.46%
3,696,089
SC 13G/A
Jul 08, 2022
blackrock inc.
2.5%
961,466
SC 13G
Feb 11, 2022
capital world investors
11.0%
4,225,688
SC 13G/A
Feb 11, 2022
mrsny randall ph.d.
9.46%
3,644,500
SC 13G/A
Feb 11, 2022
mahmood tahir ph.d.
9.45%
3,641,000
SC 13G/A
Feb 04, 2022
blackrock inc.
5.0%
1,939,444
SC 13G
Sep 10, 2021
capital research global investors
4.4%
1,708,437
SC 13G/A

Recent SEC filings of Applied Molecular Transport Inc.

View All Filings
Date Filed Form Type Document
Feb 14, 2024
SC 13G/A
Major Ownership Report
Jan 09, 2024
15-12G
15-12G
Jan 05, 2024
SC 13D/A
13D - Major Acquisition
Jan 02, 2024
EFFECT
EFFECT
Jan 02, 2024
POS AM
POS AM
Jan 02, 2024
POSASR
POSASR
Jan 02, 2024
S-8 POS
Employee Benefits Plan
Jan 02, 2024
S-8 POS
Employee Benefits Plan
Jan 02, 2024
S-8 POS
Employee Benefits Plan
Dec 29, 2023
4
Insider Trading

Peers (Alternatives to Applied Molecular Transport Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
36.3B
6.8B
-16.59% -47.80%
-7.7
5.3
-64.45% -156.37%
22.4B
152.6K
-0.77% 465779.94%
-2.4K
146.8K
- -9.98%
19.2B
1.8B
-23.99% -31.71%
-43.66
10.51
76.23% 61.08%
16.4B
2.4B
-4.89% -18.90%
98.05
6.79
15.42% 18.43%
13.3B
3.7B
-7.62% -26.87%
22.19
3.59
8.87% 75.42%
MID-CAP
7.7B
396.6M
-2.06% 34.31%
-14.57
19.42
425.83% 18.94%
6.3B
-
-3.85% 226.12%
-10.06
60.35
54.84% -25.61%
4.5B
240.7M
-19.08% -10.99%
-15.05
18.56
-1.03% -92.09%
4.0B
726.4M
-12.60% 32.37%
-64.55
5.45
40.45% 71.62%
3.9B
270.6M
8.92% 47.81%
-16.3
14.41
440.80% -27.84%
SMALL-CAP
2.0B
398.2M
-3.38% -9.50%
28.08
5.03
85.90% -14.05%
752.9M
983.7M
-9.17% -57.89%
-1.38
0.77
-50.36% 17.16%
217.0M
4.9M
-14.18% -58.18%
-1.32
44.39
-57.57% 50.48%
154.8M
881.7K
289.54% 381.25%
-3.26
112.79
-77.61% -13.74%
4.3M
2.1M
7.69% 44.16%
-0.08
2.14
-13.45% 11.54%

Applied Molecular Transport Inc. News

Latest updates
San Francisco Business Times 5 months ago

Applied Molecular Transport Inc. Earnings Report: Key Takeaways & Analysis

Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Assets-19.8%20.0025.0083.0010712514718221420722412614015817310639.00
  Current Assets-19.3%19.0023.0046.0064.0080.00101133167188206112132149166-33.00
    Cash Equivalents-19.4%18.0022.0042.0061.0076.0096.0012616115215926.006.0011.0023.006.0013.00
  Net PPE-20.5%0.000.003.008.009.009.009.007.006.007.007.008.008.007.00-4.00
Liabilities-12.5%4.004.0047.0047.0046.0050.0054.0050.0020.0016.0013.009.009.008.006.005.00
  Current Liabilities-1.1%4.004.0017.0015.0014.0016.0018.0014.0010.008.009.008.008.007.00-4.00
Shareholder's Equity-21.3%16.0021.0036.0061.0078.0098.001281641882081141321491652.001.00
  Retained Earnings-1.7%-418-411-393-365-343-318-282-239-209-183-159-139-120-103--72.79
  Additional Paid-In Capital0.6%434432430427422416410403397392273271269269-1.00
Shares Outstanding3.7%41.0039.0039.0039.0039.0039.0039.0039.0038.0037.0035.0023.00----
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q2
Cashflow From Operations79.6%-4,399-21,523-19,298-14,816-19,564-28,389-31,131-22,480-17,040-22,141-20,948-16,705-13,581-14,897-13,711---
  Share Based Compensation38.5%2,5311,8283,2234,9625,8425,5906,7735,4774,9374,3331,9511,078762659557---
Cashflow From Investing-96.9%45.001,471-7.00-6.00-223-2,406-1,51729,1129,60841,56541,92110,8042,246-130,9448,608---
Cashflow From Financing100.0%--178-69.00-53.00-132145-693734432113,829303430-752163,275-1,657---

AMTI Income Statement

2023-09-30
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating expenses:    
Research and development$ 250$ 18,233$ 15,796$ 72,273
General and administrative7,0077,28120,80428,052
Restructuring, impairment, and related charges(40)1216,8323,799
Total operating expenses7,21725,52653,432104,124
Loss from operations(7,217)(25,526)(53,432)(104,124)
Interest income, net2833211,281393
Other income (expense), net(3)(1)(36)5
Net loss$ (6,937)$ (25,206)$ (52,187)$ (103,726)
Net loss per share, basic (in dollars per share)$ (0.17)$ (0.65)$ (1.32)$ (2.68)
Net loss per share, diluted (in dollars per share)$ (0.17)$ (0.65)$ (1.32)$ (2.68)
Weighted-average shares of common stock outstanding, basic (in shares)39,751,02838,914,57039,426,21838,769,226
Weighted-average shares of common stock outstanding, diluted (in shares)39,751,02838,914,57039,426,21838,769,226

AMTI Balance Sheet

2023-09-30
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 18,103$ 61,145
Prepaid expenses4572,688
Other current assets259186
Total current assets18,81964,019
Property and equipment, net318,183
Operating lease right-of-use assets1,16533,222
Finance lease right-of-use assets0584
Restricted cash0916
Other assets0522
Total assets20,015107,446
Current liabilities:  
Accounts payable1611,583
Accrued expenses2,2618,660
Lease liabilities, operating lease - current1,3534,639
Lease liabilities, finance lease - current0205
Total current liabilities3,77515,087
Lease liabilities, operating lease031,228
Lease liabilities, finance lease049
Other liabilities0244
Total liabilities3,77546,608
Commitments and contingencies
Stockholders’ equity:  
Preferred stock, $0.0001 par value: 50,000,000 shares authorized; none issued and outstanding00
Common stock, $0.0001 par value, 450,000,000 shares authorized; 40,893,507 and 39,181,801 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively44
Additional paid-in capital434,393426,804
Accumulated deficit(418,157)(365,970)
Total stockholders’ equity16,24060,838
Total liabilities and stockholders’ equity$ 20,015$ 107,446
AMTI
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.
 CEO
 WEBSITEwww.appliedmt.com
 EMPLOYEES13

Applied Molecular Transport Inc. Frequently Asked Questions


What is the ticker symbol for Applied Molecular Transport Inc.? What does AMTI stand for in stocks?

AMTI is the stock ticker symbol of Applied Molecular Transport Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Applied Molecular Transport Inc. (AMTI)?

As of Fri Dec 29 2023, market cap of Applied Molecular Transport Inc. is 10.75 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMTI stock?

You can check AMTI's fair value in chart for subscribers.

What is the fair value of AMTI stock?

You can check AMTI's fair value in chart for subscribers. The fair value of Applied Molecular Transport Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Applied Molecular Transport Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMTI so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Applied Molecular Transport Inc. a good stock to buy?

The fair value guage provides a quick view whether AMTI is over valued or under valued. Whether Applied Molecular Transport Inc. is cheap or expensive depends on the assumptions which impact Applied Molecular Transport Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMTI.